Countries across PSI’s global network are implementing programs aimed to increase awareness, detection and management of Type 2 diabetes among populations at greatest risk.
Type 2 diabetes is the most common form of the disease. It currently affects over 415 million people worldwide, with 80% of cases in low- and middle-income countries. The International Diabetes Federation estimates that over 65 million men and women in India alone are living with Type 2 diabetes. Almost half of the cases of diabetes worldwide (46%) remain undiagnosed.
When left untreated, Type 2 diabetes can lead to serious health problems, including heart attacks, strokes, kidney disease, blindness, amputation of extremities, and death. Often, diabetes increases risk for development of other serious conditions, such as cardiovascular disease and tuberculosis. Certain medications, including some used for people living with HIV, have also been shown to increase risk of development of Type 2 diabetes.
Maintaining blood glucose, blood pressure and cholesterol at – or close to – normal levels can delay or prevent diabetes complications. For these reasons, people with diabetes need regular monitoring.
Active and effective participation of people with diabetes in the control and treatment of their disease is an essential component of good diabetes care. Given the large number of undiagnosed diabetes, PSI programs strive to provide relevant information on the importance of diabetes prevention and control for the general population, as well as those at high risk for disease. We also work to ensure that providers are trained to offer their patients relevant tools and resources and knowledge to make informed choices and improve health.
Making a Difference
With support from the Eli Lilly & Company under the Lilly NCD Partnership, PSI/India and its collaborating partners, the Public Health Foundation of India and Project HOPE, are collaborating on Project Uday (meaning ‘uprise’). It aims to reach 400,000 people at risk of developing Type 2 diabetes and hypertension. The project is located in Sonepat in the north and Vizag on India’s east coast.
Project Uday focuses on behavior change communication and awareness activities, in addition to health provider training to ensure adults with diabetes and hypertension maintain their treatment regimens. PSI/India’s specific role is to lead on the development and dissemination of the campaign’s communications materials, community mobilization and training for roughly 300 participating pharmacists on control and treatment of the disease.
The PSI/India team has conducted both a qualitative and a population-based study of roughly 2,200 adult men and women. The aim was to capture their understanding of Type 2 diabetes, its risk factors, and the triggers and barriers for early diagnosis and treatment adherence among patients. Evidence from this study are being used to guide program priorities and resources for maximum impact. The Public Health Foundation of India will establish ten hospital-based diabetes registries to evaluate and improve quality of care among both patients and providers.